These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 9365436

  • 1. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy.
    Garza-Ocañas L, Torres-Alanís O, Piñeyro-López A.
    J Toxicol Clin Toxicol; 1997; 35(6):653-5. PubMed ID: 9365436
    [Abstract] [Full Text] [Related]

  • 2. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride.
    Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Aposhian MM, Dart RC, Woods JS, Ostrosky-Wegman P, Gonsebatt ME, Aposhian HV.
    J Pharmacol Exp Ther; 1996 May; 277(2):938-44. PubMed ID: 8627576
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of urinary mercury excretion after administration of 2,3-dimercapto-1-propane sulfonic acid to occupationally exposed men.
    Torres-Alanís O, Garza-Ocañas L, Pineyro-Lopez A.
    J Toxicol Clin Toxicol; 1995 May; 33(6):717-20. PubMed ID: 8523500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
    Nerudová J, Cábelková Z, Frantík E, Lukás E, Urban P, Bláha K, Pelclová D, Lebedová J, Cikrt M.
    Int J Occup Med Environ Health; 2000 May; 13(2):131-46. PubMed ID: 10967843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma and urine dimercaptopropanesulfonate concentrations after dermal application of transdermal DMPS (TD-DMPS).
    Cohen JP, Ruha AM, Curry SC, Biswas K, Westenberger B, Ye W, Caldwell KL, Lovecchio F, Burkhart K, Samia N.
    J Med Toxicol; 2013 Mar; 9(1):9-15. PubMed ID: 23143832
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.
    Pingree SD, Simmonds PL, Rummel KT, Woods JS.
    Toxicol Sci; 2001 Jun; 61(2):234-40. PubMed ID: 11353132
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic value of a chelating agent in patients with symptoms allegedly caused by amalgam fillings.
    Vamnes JS, Eide R, Isrenn R, Höl PJ, Gjerdet NR.
    J Dent Res; 2000 Mar; 79(3):868-74. PubMed ID: 10765962
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.